Skip to content

    Recently Viewed

      Listening...

      Leadership

      Johnson & Johnson Names CEO Joaquin Duato as Chairman of the Board

      Alex Gorsky to Step Down After 30-Year Career at Johnson & Johnson

      Johnson & Johnson Appoints Larry Merlo as Non-Executive Chair Designate of Planned New Consumer Health Company

      Former President and CEO of CVS Health, Merlo Will Assume Board Leadership Role with the New Consumer Health Company and Support Preparations for the Planned Separation, Expected to Occur in 2023

      Johnson & Johnson Appoints Thibaut Mongon as CEO Designate of Planned New Consumer Health Company

      The Company has also appointed Paul Ruh as CFO Designate Mongon and Ruh to Assume New Leadership Roles Upon the Completion of the Planned Separation of the Consumer Health Business Planned Separation Expected to Occur in 2023
      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.